{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:30:43Z","timestamp":1792042243523,"version":"4.4.0"},"reference-count":354,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CB07\/08\/0016"],"award-info":[{"award-number":["CB07\/08\/0016"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["MICIU\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MICIU\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Spanish Association Against Cancer Scientific Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["MICIU\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MICIU\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["RYC2022\\u2013036653-I"],"award-info":[{"award-number":["RYC2022\\u2013036653-I"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["25CDA1451842"],"award-info":[{"award-number":["25CDA1451842"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espana Ministerio de Ciencia e Innovacion","doi-asserted-by":"publisher","award":["PID2024\\u2013159272OB-I00"],"award-info":[{"award-number":["PID2024\\u2013159272OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espana Ministerio de Ciencia e Innovacion","doi-asserted-by":"publisher","award":["PID2022\\u2013137186OB-I00"],"award-info":[{"award-number":["PID2022\\u2013137186OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["RYC-201722879"],"award-info":[{"award-number":["RYC-201722879"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003508","name":"University of Valencia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003508","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","award":["AE-3649639"],"award-info":[{"award-number":["AE-3649639"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.semcancer.2026.01.003","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:25:21Z","timestamp":1768004721000},"page":"83-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease"],"prefix":"10.1016","volume":"119","author":[{"given":"Maria","family":"Llena-Meler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Canfran-Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Madrigal-Matute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Rotllan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2026.01.003_bib1","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990-2022","volume":"82","author":"Mensah","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2026.01.003_bib3","first-page":"S97","article-title":"Atherosclerosis: a cancer of the blood vessels?","volume":"116","author":"Ross","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.arcmed.2017.03.005","article-title":"Atherosclerosis and cancer; a resemblance with far-reaching implications","volume":"48","author":"Tapia-Vieyra","year":"2017","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.semcancer.2026.01.003_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/232464","article-title":"Cell stress proteins in atherothrombosis","volume":"2012","author":"Madrigal-Matute","year":"2012","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.semcancer.2026.01.003_bib6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.freeradbiomed.2015.06.001","article-title":"Thioredoxin-1\/peroxiredoxin-1 as sensors of oxidative stress mediated by NADPH oxidase activity in atherosclerosis","volume":"86","author":"Madrigal-Matute","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.semcancer.2026.01.003_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1749-6632.2001.tb03949.x","article-title":"Atherosclerosis and cancer: common molecular pathways of disease development and progression","volume":"947","author":"Ross","year":"2001","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib8","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.032920","article-title":"The contributions of cancer cell metabolism to metastasis","volume":"11","author":"Pascual","year":"2018","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.semcancer.2026.01.003_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semcancer.2024.12.002","article-title":"Theoretical framework and emerging challenges of lipid metabolism in cancer","volume":"108","author":"Gu","year":"2025","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib10","unstructured":"INE. National Health Survey 2017. SNHS 2017, <\u3008https:\/\/www.ine.es\/en\/metodologia\/t15\/t153041917_en.pdf\u3009> (2017)."},{"key":"10.1016\/j.semcancer.2026.01.003_bib11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ehb.2016.05.004","article-title":"Disentangling effects of socioeconomic status on obesity: a cross-sectional study of the Spanish adult population","volume":"22","author":"Merino Ventosa","year":"2016","journal-title":"Econ. Hum. Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41574-018-0126-x","article-title":"The obese adipose tissue microenvironment in cancer development and progression","volume":"15","author":"Quail","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2026.01.003_bib14","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030361","article-title":"The epidemiology of prostate cancer","volume":"8","author":"Pernar","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.semcancer.2026.01.003_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.semcancer.2023.05.002","article-title":"Obesity-induced changes in cancer cells and their microenvironment: Mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism","volume":"93","author":"Lee-Rueckert","year":"2023","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.canlet.2013.03.005","article-title":"Vascular permeability changes involved in tumor metastasis","volume":"335","author":"Garcia-Roman","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2026.01.003_bib17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41569-024-01017-x","article-title":"Cardiovascular disease and cancer: shared risk factors and mechanisms","volume":"21","author":"Wilcox","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib18","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a037036","article-title":"Dysregulation of cell death in human chronic inflammation","volume":"12","author":"Li","year":"2020","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib19","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/carcin\/bgv123","article-title":"Immunosuppression associated with chronic inflammation in the tumor microenvironment","volume":"36","author":"Wang","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2026.01.003_bib20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/cr.2017.8","article-title":"Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis","volume":"27","author":"Luo","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.semcancer.2026.01.003_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2024.107419","article-title":"Macrophages in vascular disease: roles of mitochondria and metabolic mechanisms","volume":"156","author":"Mackay","year":"2024","journal-title":"Vasc. Pharm."},{"key":"10.1016\/j.semcancer.2026.01.003_bib22","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/cvr\/cvx108","article-title":"The role of infiltrating immune cells in dysfunctional adipose tissue","volume":"113","author":"Guzik","year":"2017","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.semcancer.2026.01.003_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1103149","article-title":"Tumor-associated macrophage polarization in the inflammatory tumor microenvironment","volume":"13","author":"Zou","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib24","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3389\/fimmu.2017.01129","article-title":"Adipocytes and macrophages interplay in the orchestration of tumor microenvironment: new implications in cancer progression","volume":"8","author":"Correa","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib25","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00125-013-2885-1","article-title":"Adipose tissue hypoxia induces inflammatory M1 polarity of macrophages in an HIF-1alpha-dependent and HIF-1alpha-independent manner in obese mice","volume":"56","author":"Fujisaka","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.semcancer.2026.01.003_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.741305","article-title":"Tumor-associated macrophages and their functional transformation in the hypoxic tumor microenvironment","volume":"12","author":"He","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib27","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","article-title":"Reactive oxygen species in metabolic and inflammatory signaling","volume":"122","author":"Forrester","year":"2018","journal-title":"Circ. Res"},{"key":"10.1016\/j.semcancer.2026.01.003_bib28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","article-title":"Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis","volume":"120","author":"Forstermann","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.semcancer.2026.01.003_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2606928","article-title":"Reactive oxygen species bridge the gap between chronic inflammation and tumor development","volume":"2022","author":"Yu","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.semcancer.2026.01.003_bib30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jcb.25263","article-title":"Regulation of adipose tissue stem cells angiogenic potential by tumor necrosis factor-alpha","volume":"117","author":"Zubkova","year":"2016","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.semcancer.2026.01.003_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mce.2009.08.018","article-title":"Adipose tissue as an endocrine organ","volume":"316","author":"Galic","year":"2010","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12997","article-title":"Adipokine dysregulation and adipose tissue inflammation in human obesity","volume":"48","author":"Unamuno","year":"2018","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.semcancer.2026.01.003_bib33","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2337\/db06-1656","article-title":"Visceral fat adipokine secretion is associated with systemic inflammation in obese humans","volume":"56","author":"Fontana","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.semcancer.2026.01.003_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.semcancer.2026.01.003_bib35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41467-019-08449-x","article-title":"Costimulation of type-2 innate lymphoid cells by GITR promotes effector function and ameliorates type 2 diabetes","volume":"10","author":"Galle-Treger","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.01.003_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1176\/jnp.3.2.157","article-title":"Neuropsychological correlates of obsessive characteristics in Tourette syndrome","volume":"3","author":"Bornstein","year":"1991","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13783","article-title":"Age-associated adipose tissue inflammation promotes monocyte chemotaxis and enhances atherosclerosis","volume":"22","author":"Song","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.semcancer.2026.01.003_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mce.2017.02.002","article-title":"The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5","volume":"462","author":"Guaita-Esteruelas","year":"2018","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13833","article-title":"Lipids and adipocytes involvement in tumor progression with a focus on obesity and diet","volume":"25","author":"Calabrese","year":"2024","journal-title":"Obes. Rev."},{"key":"10.1016\/j.semcancer.2026.01.003_bib40","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.semcancer.2026.01.003_bib41","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/CIRCULATIONAHA.118.035516","article-title":"Synergistic opportunities in the interplay between cancer screening and cardiovascular disease risk assessment: together we are stronger","volume":"138","author":"Handy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.semcancer.2026.01.003_bib42","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.tcb.2014.06.001","article-title":"Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment","volume":"24","author":"Ackerman","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib43","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1161\/CIRCULATIONAHA.123.067587","article-title":"Atherosclerosis is a smooth muscle cell-driven tumor-like disease","volume":"149","author":"Pan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.semcancer.2026.01.003_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411786","article-title":"Atherosclerosis, diabetes mellitus, and cancer: common epidemiology, shared mechanisms, and future management","volume":"24","author":"Katsi","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107513","article-title":"Identifying shared transcriptional risk patterns between atherosclerosis and cancer","volume":"26","author":"Baylis","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.semcancer.2026.01.003_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40880-018-0301-4","article-title":"Lipid metabolism reprogramming and its potential targets in cancer","volume":"38","author":"Cheng","year":"2018","journal-title":"Cancer Commun"},{"key":"10.1016\/j.semcancer.2026.01.003_bib47","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer","volume":"16","author":"Rohrig","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib48","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature11706","article-title":"How cancer metabolism is tuned for proliferation and vulnerable to disruption","volume":"491","author":"Schulze","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.01.003_bib49","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology","volume":"13","author":"Shimano","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib50","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12032-014-0391-z","article-title":"Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer","volume":"32","author":"Cai","year":"2015","journal-title":"Med Oncol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib51","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1007\/s13277-013-1510-8","article-title":"Fatty acid synthase (FASN) levels in serum of colorectal cancer patients: correlation with clinical outcomes","volume":"35","author":"Long","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108951","article-title":"Stearoyl-CoA desaturase 1 as a therapeutic biomarker: focusing on cancer stem cells","volume":"24","author":"Min","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.01.003_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074875","article-title":"Fenretinide corrects the imbalance between omega-6 to omega-3 polyunsaturated fatty acids and inhibits macrophage inflammatory mediators via the ERK pathway","volume":"8","author":"Lachance","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2026.01.003_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004584","article-title":"Lipid-loaded macrophages as new therapeutic target in cancer","volume":"10","author":"Marelli","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib56","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41420-024-02184-z","article-title":"Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity","volume":"10","author":"Cuyas","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.semcancer.2026.01.003_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0150-x","article-title":"The implications of signaling lipids in cancer metastasis","volume":"50","author":"Luo","year":"2018","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.semcancer.2026.01.003_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.577420","article-title":"Alterations of lipid metabolism in cancer: implications in prognosis and treatment","volume":"10","author":"Fernandez","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41389-023-00460-8","article-title":"Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies","volume":"12","author":"Vanauberg","year":"2023","journal-title":"Oncogenesis"},{"key":"10.1016\/j.semcancer.2026.01.003_bib60","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10549-012-2354-4","article-title":"High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients","volume":"137","author":"Holder","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.semcancer.2026.01.003_bib61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12032-014-0015-7","article-title":"Increased expression of phospho-acetyl-CoA carboxylase protein is an independent prognostic factor for human gastric cancer without lymph node metastasis","volume":"31","author":"Fang","year":"2014","journal-title":"Med Oncol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib62","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tem.2014.10.001","article-title":"Cholesterol and breast cancer pathophysiology","volume":"25","author":"Nelson","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2026.01.003_bib63","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41467-017-00910-z","article-title":"The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells","volume":"8","author":"Baek","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.01.003_bib64","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.9515","article-title":"Association of statin use with cancer- and noncancer-associated survival among patients with breast cancer in Asia","volume":"6","author":"Chang","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.semcancer.2026.01.003_bib65","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2024.04.007","article-title":"Emerging targets in lipid metabolism for cancer therapy","volume":"45","author":"Terry","year":"2024","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib66","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41419-025-07661-6","article-title":"Targeting oncogenic activation of FLT3\/SREBP\/FASN promotes the therapeutic effect of quizartinib involving disruption of mitochondrial phospholipids","volume":"16","author":"Yin","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.semcancer.2026.01.003_bib67","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/160104","article-title":"Lipids and lipoproteins in atherosclerosis","volume":"2011","author":"Chroni","year":"2011","journal-title":"J. Lipids"},{"key":"10.1016\/j.semcancer.2026.01.003_bib68","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1161\/ATVBAHA.120.315639","article-title":"Per-Particle Triglyceride-Rich Lipoproteins Imply Higher Myocardial Infarction Risk Than Low-Density Lipoproteins: Copenhagen General Population Study","volume":"41","author":"Johansen","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib69","first-page":"206","article-title":"& Grupo de Trabajo Dislipemia Aterogenica, S. E. d. A. Remnant cholesterol, vascular risk, and prevention of atherosclerosis","volume":"35","author":"Pinto","year":"2023","journal-title":"Clin. Invest. Arterioscler."},{"key":"10.1016\/j.semcancer.2026.01.003_bib70","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11883-014-0407-3","article-title":"Noncoding RNAs and atherosclerosis","volume":"16","author":"Aryal","year":"2014","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.semcancer.2026.01.003_bib71","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.semcancer.2026.01.003_bib72","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/eurheartj\/ehx566","article-title":"Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials","volume":"39","author":"Koskinas","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.semcancer.2026.01.003_bib73","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Cholesterol Treatment Trialists, C","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2026.01.003_bib74","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2026.01.003_bib75","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature04399","article-title":"Role of cholesterol and lipid organization in disease","volume":"438","author":"Maxfield","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.01.003_bib76","doi-asserted-by":"crossref","first-page":"212","DOI":"10.31083\/j.rcm2306212","article-title":"Mechanism of Hypercholesterolemia-Induced Atherosclerosis","volume":"23","author":"Prasad","year":"2022","journal-title":"Rev. Cardiovasc Med."},{"key":"10.1016\/j.semcancer.2026.01.003_bib77","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10120-021-01241-1","article-title":"Nationwide cohort study: cholesterol level is inversely related with the risk of gastric cancer among postmenopausal women","volume":"25","author":"Lim","year":"2022","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib78","first-page":"943","article-title":"Association between blood lipid levels and the risk of liver cancer: a systematic review and meta-analysis","volume":"35","author":"Zhang","year":"2024","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.semcancer.2026.01.003_bib79","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-020-00963-6","article-title":"Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals","volume":"13","author":"Pedersen","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib80","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/ijc.34621","article-title":"Plasma total cholesterol concentration and risk of higher-grade prostate cancer: A nested case-control study and a dose-response meta-analysis","volume":"153","author":"Liu","year":"2023","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib81","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211061033","article-title":"Association between serum lipids and breast cancer risk in premenopausal women: systematic review and meta-analysis","volume":"49","author":"Wu","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.semcancer.2026.01.003_bib82","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.1990.03440150091032","article-title":"Declining serum cholesterol levels prior to diagnosis of colon cancer. A time-trend, case-control study","volume":"263","author":"Winawer","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.semcancer.2026.01.003_bib83","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/annonc\/mdn736","article-title":"Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: a prospective 19-year follow-up study","volume":"20","author":"Strasak","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib84","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1073\/pnas.87.7.2598","article-title":"Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy","volume":"87","author":"Vitols","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcancer.2026.01.003_bib85","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(89)91790-X","article-title":"Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate","author":"Henriksson","year":"1989","journal-title":"Lancet 2"},{"key":"10.1016\/j.semcancer.2026.01.003_bib86","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.coph.2012.07.001","article-title":"Post-lanosterol biosynthesis of cholesterol and cancer","volume":"12","author":"Lasuncion","year":"2012","journal-title":"Curr. Opin. Pharm."},{"key":"10.1016\/j.semcancer.2026.01.003_bib87","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00018-011-0857-5","article-title":"Regulation of cholesterol homeostasis","volume":"69","author":"Goedeke","year":"2012","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib88","first-page":"3602","article-title":"Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin","volume":"51","author":"Keyomarsi","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2026.01.003_bib89","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1091\/mbc.6.9.1197","article-title":"Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation","volume":"6","author":"Poon","year":"1995","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.semcancer.2026.01.003_bib90","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/sj.onc.1202322","article-title":"Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53","volume":"17","author":"Rao","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2026.01.003_bib91","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cell.2011.12.017","article-title":"Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway","volume":"148","author":"Freed-Pastor","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.01.003_bib92","first-page":"3223","article-title":"Cholesterol biosynthesis inhibitor RO 48-8071 suppresses growth of hormone-dependent and castration-resistant prostate cancer cells","author":"Liang","year":"2016","journal-title":"Onco Targets Ther. 9"},{"key":"10.1016\/j.semcancer.2026.01.003_bib93","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ijc.30706","article-title":"P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models","volume":"141","author":"Lopez-Barcons","year":"2017","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib94","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/1078-0432.CCR-18-1854","article-title":"Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells","volume":"25","author":"Agnihotri","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2026.01.003_bib95","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bbrc.2012.07.136","article-title":"Triparanol suppresses human tumor growth in vitro and in vivo","volume":"425","author":"Bi","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2026.01.003_bib96","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107682118","article-title":"Desmosterol suppresses macrophage inflammasome activation and protects against vascular inflammation and atherosclerosis","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcancer.2026.01.003_bib97","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1158\/0008-5472.CAN-18-1487","article-title":"The effects of cholesterol-derived oncometabolites on nuclear receptor function in cancer","volume":"78","author":"Silvente-Poirot","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2026.01.003_bib98","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.122.059062","article-title":"Macrophage-derived 25-hydroxycholesterol promotes vascular inflammation, atherogenesis, and lesion remodeling","volume":"147","author":"Canfran-Duque","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.semcancer.2026.01.003_bib99","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cmet.2014.05.013","article-title":"The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha","volume":"20","author":"Umetani","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2026.01.003_bib100","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.immuni.2024.03.021","article-title":"25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages","volume":"57","author":"Xiao","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2026.01.003_bib101","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13058-020-01347-x","article-title":"CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients","volume":"22","author":"Kimbung","year":"2020","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.semcancer.2026.01.003_bib102","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jsbmb.2016.06.010","article-title":"Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: results of the OXYTAM study","volume":"169","author":"Dalenc","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib103","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/djy115","article-title":"Circulating 27-hydroxycholesterol and breast cancer risk: results from the EPIC-Heidelberg Cohort","volume":"111","author":"Lu","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.semcancer.2026.01.003_bib104","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1158\/1055-9965.EPI-18-1083","article-title":"Intratumoral Sterol-27-hydroxylase (CYP27A1) expression in relation to cholesterol synthesis and vitamin D signaling and its association with lethal prostate cancer","volume":"28","author":"Khan","year":"2019","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.semcancer.2026.01.003_bib105","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1158\/0008-5472.CAN-16-2738","article-title":"CYP27A1 loss dysregulates cholesterol homeostasis in prostate cancer","volume":"77","author":"Alfaqih","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2026.01.003_bib106","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/ncomms2835","article-title":"Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties","volume":"4","author":"de Medina","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.01.003_bib107","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/s41467-017-01948-9","article-title":"Dendrogenin A drives LXR to trigger lethal autophagy in cancers","volume":"8","author":"Segala","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.01.003_bib108","doi-asserted-by":"crossref","first-page":"E9346","DOI":"10.1073\/pnas.1707965114","article-title":"Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor","volume":"114","author":"Voisin","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"14","key":"10.1016\/j.semcancer.2026.01.003_bib109","article-title":"Systematic classification of non-coding RNAs by epigenomic similarity","volume":"14","author":"Dozmorov","year":"2013","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.semcancer.2026.01.003_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051310","article-title":"Noncoding RNA:RNA regulatory networks in cancer","volume":"19","author":"Chan","year":"2018","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib111","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/bph.16412","article-title":"Targeting noncoding RNAs to treat atherosclerosis","volume":"182","author":"Sopic","year":"2025","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.semcancer.2026.01.003_bib112","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11883-020-00872-6","article-title":"The Long Non-coding Road to Atherosclerosis","volume":"22","author":"Josefs","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.semcancer.2026.01.003_bib113","article-title":"Long Non-Coding RNAs in the Regulation of Gene Expression: Physiology and Disease","volume":"5","author":"Fernandes","year":"2019","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.semcancer.2026.01.003_bib114","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11883-013-0322-z","article-title":"MicroRNAs and atherosclerosis","volume":"15","author":"Madrigal-Matute","year":"2013","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.semcancer.2026.01.003_bib115","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.atherosclerosis.2016.01.025","article-title":"microRNAs in lipoprotein metabolism and cardiometabolic disorders","volume":"246","author":"Rotllan","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semcancer.2026.01.003_bib116","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.cellbio.23.090506.123406","article-title":"microRNA functions","volume":"23","author":"Bushati","year":"2007","journal-title":"Annu Rev. Cell Dev. Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib117","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.01.003_bib118","doi-asserted-by":"crossref","first-page":"D203","DOI":"10.1093\/nar\/gkv1252","article-title":"NONCODE 2016: an informative and valuable data source of long non-coding RNAs","volume":"44","author":"Zhao","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.semcancer.2026.01.003_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029837","article-title":"Modulation of miRNA expression by dietary polyphenols in apoE deficient mice: a new mechanism of the action of polyphenols","volume":"7","author":"Milenkovic","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2026.01.003_bib120","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1017\/S0007114514000579","article-title":"Maternal high-fat diet consumption modulates hepatic lipid metabolism and microRNA-122 (miR-122) and microRNA-370 (miR-370) expression in offspring","volume":"111","author":"Benatti","year":"2014","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.semcancer.2026.01.003_bib121","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-nutr-062220-030244","article-title":"Long Noncoding RNAs That Function in Nutrition: Lnc-ing Nutritional Cues to Metabolic Pathways","volume":"42","author":"Lovell","year":"2022","journal-title":"Annu Rev. Nutr."},{"key":"10.1016\/j.semcancer.2026.01.003_bib122","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41569-018-0154-1","article-title":"The lncRNA CHROME regulates cholesterol homeostasis","volume":"16","author":"Le Bras","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib123","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3945\/an.116.013839","article-title":"Nutrition, microRNAs, and Human Health","volume":"8","author":"Cui","year":"2017","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.semcancer.2026.01.003_bib124","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1161\/ATVBAHA.118.310227","article-title":"Impact of miRNA in Atherosclerosis","volume":"38","author":"Lu","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib125","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.semcancer.2026.01.003_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051723","article-title":"Regulatory mechanism of MicroRNA expression in cancer","volume":"21","author":"Ali Syeda","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib127","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/bioinformatics\/btx627","article-title":"OncomiR: an online resource for exploring pan-cancer microRNA dysregulation","volume":"34","author":"Wong","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.semcancer.2026.01.003_bib128","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1186\/s12885-018-5085-z","article-title":"OMCD: OncomiR Cancer database","volume":"18","author":"Sarver","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib129","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/bioinformatics\/btt014","article-title":"miRCancer: a microRNA-cancer association database constructed by text mining on literature","volume":"29","author":"Xie","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.semcancer.2026.01.003_bib130","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/cdd.2013.125","article-title":"The miR-17\/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease","volume":"20","author":"Mogilyansky","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.semcancer.2026.01.003_bib131","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","article-title":"A microRNA polycistron as a potential human oncogene","volume":"435","author":"He","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.01.003_bib132","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","article-title":"c-Myc-regulated microRNAs modulate E2F1 expression","volume":"435","author":"O'Donnell","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.01.003_bib133","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1074\/jbc.C600252200","article-title":"Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors","volume":"282","author":"Woods","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2026.01.003_bib134","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ccr.2008.02.013","article-title":"E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer","volume":"13","author":"Petrocca","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2026.01.003_bib135","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/MCB.01977-07","article-title":"MicroRNAs in the miR-106b family regulate p21\/CDKN1A and promote cell cycle progression","volume":"28","author":"Ivanovska","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib136","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2008.02.020","article-title":"Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage","volume":"132","author":"Koralov","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.01.003_bib137","doi-asserted-by":"crossref","first-page":"9136","DOI":"10.1073\/pnas.0508889103","article-title":"microRNAs exhibit high frequency genomic alterations in human cancer","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcancer.2026.01.003_bib138","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1128\/MCB.00242-06","article-title":"Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA","volume":"26","author":"Hossain","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib139","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1126\/science.1174381","article-title":"MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice","volume":"324","author":"Bonauer","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2026.01.003_bib140","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/path.2586","article-title":"MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets","volume":"219","author":"Baffa","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib141","first-page":"1764","article-title":"The functional analysis of MicroRNAs involved in NF-kappaB signaling","volume":"20","author":"Yang","year":"2016","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib142","article-title":"MicroRNA-21 and its impact on signaling pathways in cervical cancer","author":"Wang","year":"2019","journal-title":"Oncol. Lett. 17 30663070"},{"key":"10.1016\/j.semcancer.2026.01.003_bib143","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1158\/0008-5472.CAN-08-1305","article-title":"MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells","volume":"68","author":"Papagiannakopoulos","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.01.003_bib144","doi-asserted-by":"crossref","first-page":"17064","DOI":"10.1002\/jcp.28457","article-title":"microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer","volume":"234","author":"Nahand","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib145","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bbadis.2011.09.018","article-title":"MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20","volume":"1822","author":"Yao","year":"2012","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.semcancer.2026.01.003_bib146","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/IGC.0000000000000694","article-title":"Circulating MicroRNA-21 Is Involved in Lymph Node Metastasis in Cervical Cancer by Targeting RASA1","volume":"26","author":"Zhang","year":"2016","journal-title":"Int J. Gynecol. Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib147","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.3892\/or.2015.3931","article-title":"Overexpression of miR-21 promotes the proliferation and migration of cervical cancer cells via the inhibition of PTEN","volume":"33","author":"Xu","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2026.01.003_bib148","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00404-017-4598-z","article-title":"MicroRNA-21 promotes proliferation, migration, and invasion of cervical cancer through targeting TIMP3","volume":"297","author":"Zhang","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.semcancer.2026.01.003_bib149","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/138945010791591403","article-title":"MicroRNA-21: from cancer to cardiovascular disease","volume":"11","author":"Jazbutyte","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.semcancer.2026.01.003_bib150","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1161\/ATVBAHA.111.229559","article-title":"MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities","volume":"31","author":"Wang","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib151","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/CIRCRESAHA.106.141986","article-title":"MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation","volume":"100","author":"Ji","year":"2007","journal-title":"Circ. Res"},{"key":"10.1016\/j.semcancer.2026.01.003_bib152","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.15252\/emmm.201607492","article-title":"Macrophage deficiency of miR-21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis","volume":"9","author":"Canfran-Duque","year":"2017","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.semcancer.2026.01.003_bib153","article-title":"MicroRNA 21 is a homeostatic regulator of macrophage polarization and prevents prostaglandin E2-mediated M2 generation","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2026.01.003_bib154","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ni.1828","article-title":"Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21","volume":"11","author":"Sheedy","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2011.07.020","article-title":"miR-21, miR-210, miR-34a, and miR-146a\/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study","volume":"219","author":"Raitoharju","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semcancer.2026.01.003_bib156","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1152\/physiolgenomics.00141.2011","article-title":"The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury","volume":"44","author":"Kriegel","year":"2012","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.semcancer.2026.01.003_bib157","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3892\/br.2017.900","article-title":"Role of the microRNA-29 family in fibrotic skin diseases","volume":"6","author":"Harmanci","year":"2017","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.semcancer.2026.01.003_bib158","doi-asserted-by":"crossref","first-page":"643","DOI":"10.15252\/emmm.201506031","article-title":"Chronic miR-29 antagonism promotes favorable plaque remodeling in atherosclerotic mice","volume":"8","author":"Ulrich","year":"2016","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.semcancer.2026.01.003_bib159","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.omto.2018.12.011","article-title":"A Systematic Review of miR-29 in Cancer","volume":"12","author":"Kwon","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.semcancer.2026.01.003_bib160","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis","volume":"105","author":"van Rooij","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcancer.2026.01.003_bib161","doi-asserted-by":"crossref","first-page":"40799","DOI":"10.18632\/oncotarget.5695","article-title":"MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3","volume":"6","author":"Teng","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2026.01.003_bib162","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.celrep.2017.01.016","article-title":"Feedback Loop Regulation of SCAP\/SREBP-1 by miR-29 Modulates EGFR Signaling-Driven Glioblastoma Growth","volume":"18","author":"Ru","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcancer.2026.01.003_bib163","doi-asserted-by":"crossref","first-page":"8149","DOI":"10.1158\/0008-5472.CAN-10-0315","article-title":"Cyclin D2-cyclin-dependent kinase 4\/6 is required for efficient proliferation and tumorigenesis following Apc loss","volume":"70","author":"Cole","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.01.003_bib164","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1182\/blood-2009-03-211938","article-title":"MicroRNA 29b functions in acute myeloid leukemia","volume":"114","author":"Garzon","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.01.003_bib165","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbrc.2013.07.123","article-title":"Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer","volume":"438","author":"Tan","year":"2013","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.semcancer.2026.01.003_bib166","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/carcin\/bgv027","article-title":"miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients","volume":"36","author":"Zou","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2026.01.003_bib167","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/hep.24577","article-title":"MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression","volume":"54","author":"Fang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.semcancer.2026.01.003_bib168","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/0008-5472.CAN-14-1027","article-title":"Chaperone Hsp47 Drives Malignant Growth and Invasion by Modulating an ECM Gene Network","volume":"75","author":"Zhu","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.01.003_bib169","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbrc.2013.03.054","article-title":"MiR-29a modulates the angiogenic properties of human endothelial cells","volume":"434","author":"Yang","year":"2013","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.semcancer.2026.01.003_bib170","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1159\/000460510","article-title":"MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK\/ERK and PI3K\/Akt Signaling Pathways in Endometrial Carcinoma","volume":"41","author":"Chen","year":"2017","journal-title":"Cell Physiol. Biochem"},{"key":"10.1016\/j.semcancer.2026.01.003_bib171","doi-asserted-by":"crossref","first-page":"69436","DOI":"10.18632\/oncotarget.11683","article-title":"TNFSF15 suppresses VEGF production in endothelial cells by stimulating miR-29b expression via activation of JNK-GATA3 signals","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2026.01.003_bib172","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncb2672","article-title":"GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression","volume":"15","author":"Chou","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib173","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s12885-017-3418-y","article-title":"Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma","volume":"17","author":"Webb","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib174","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/ijc.25134","article-title":"MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K\/AKT signaling in A549 lung cancer cells","volume":"127","author":"Chetty","year":"2010","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13046-015-0169-y","article-title":"MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN","volume":"34","author":"Wang","year":"2015","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.semcancer.2026.01.003_bib176","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s12672-025-02246-3","article-title":"The potential of miR-29 in modulating tumor angiogenesis: a comprehensive review","volume":"16","author":"Zhou","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib177","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.18632\/aging.203951","article-title":"miRNA-29a inhibits atherosclerotic plaque formation by mediating macrophage autophagy via PI3K\/AKT\/mTOR pathway","volume":"14","author":"Shao","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.semcancer.2026.01.003_bib178","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23598","article-title":"MiR-29a mediates the apoptotic effects of TNF-alpha on endothelial cells through inhibiting PI3K\/AKT\/BCL-2 axis","volume":"38","author":"Cao","year":"2024","journal-title":"J. Biochem Mol. Toxicol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib179","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9627974","article-title":"Overexpression of miR-29a-3p Suppresses Proliferation, Migration, and Invasion of Vascular Smooth Muscle Cells in Atherosclerosis via Targeting TNFRSF1A","volume":"2020","author":"You","year":"2020","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.semcancer.2026.01.003_bib180","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1101\/gr.2722704","article-title":"Identification of mammalian microRNA host genes and transcription units","volume":"14","author":"Rodriguez","year":"2004","journal-title":"Genome Res"},{"key":"10.1016\/j.semcancer.2026.01.003_bib181","doi-asserted-by":"crossref","first-page":"33652","DOI":"10.1074\/jbc.M110.152090","article-title":"Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation","volume":"285","author":"Gerin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2026.01.003_bib182","doi-asserted-by":"crossref","first-page":"17321","DOI":"10.1073\/pnas.1008499107","article-title":"MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo","volume":"107","author":"Horie","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcancer.2026.01.003_bib183","doi-asserted-by":"crossref","first-page":"12228","DOI":"10.1073\/pnas.1005191107","article-title":"miR-33 links SREBP-2 induction to repression of sterol transporters","volume":"107","author":"Marquart","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcancer.2026.01.003_bib184","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.1189123","article-title":"MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis","volume":"328","author":"Najafi-Shoushtari","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2026.01.003_bib185","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1126\/science.1189862","article-title":"MiR-33 contributes to the regulation of cholesterol homeostasis","volume":"328","author":"Rayner","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2026.01.003_bib186","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1073\/pnas.1102281108","article-title":"miR-33a\/b contribute to the regulation of fatty acid metabolism and insulin signaling","volume":"108","author":"Davalos","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcancer.2026.01.003_bib187","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/00071668.2018.1564242","article-title":"Expression of miR-33 from an SREBP2 intron inhibits the expression of the fatty acid oxidation-regulatory genes CROT and HADHB in chicken liver","volume":"60","author":"Shao","year":"2019","journal-title":"Br. Poult. Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib188","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4161\/cc.11.5.19421","article-title":"Mir-33 regulates cell proliferation and cell cycle progression","volume":"11","author":"Cirera-Salinas","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2026.01.003_bib189","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature10486","article-title":"Inhibition of miR-33a\/b in non-human primates raises plasma HDL and lowers VLDL triglycerides","volume":"478","author":"Rayner","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.01.003_bib190","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1128\/MCB.00016-13","article-title":"MicroRNA 33 regulates glucose metabolism","volume":"33","author":"Ramirez","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib191","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ni.3434","article-title":"Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism","volume":"17","author":"Ouimet","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib192","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/ATVBAHA.116.308916","article-title":"microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis","volume":"37","author":"Ouimet","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib193","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCRESAHA.117.305624","article-title":"Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis","volume":"117","author":"Karunakaran","year":"2015","journal-title":"Circ. Res"},{"key":"10.1016\/j.semcancer.2026.01.003_bib194","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s13238-015-0223-8","article-title":"MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1","volume":"6","author":"Zhang","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.semcancer.2026.01.003_bib195","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12094-017-1730-2","article-title":"miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer","volume":"20","author":"Kang","year":"2018","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib196","doi-asserted-by":"crossref","first-page":"60243","DOI":"10.18632\/oncotarget.19521","article-title":"miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer","volume":"8","author":"Karatas","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2026.01.003_bib197","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3892\/or.2017.5780","article-title":"Suppression of SIRT6 by miR-33a facilitates tumor growth of glioma through apoptosis and oxidative stress resistance","volume":"38","author":"Chang","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2026.01.003_bib198","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.biopha.2018.09.059","article-title":"PNMA1, regulated by miR-33a-5p, promotes proliferation and EMT in hepatocellular carcinoma by activating the Wnt\/beta-catenin pathway","volume":"108","author":"Liu","year":"2018","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.semcancer.2026.01.003_bib199","article-title":"DNA Methylation mediated down-regulating of MicroRNA-33b and its role in gastric cancer","volume":"6","author":"Yin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2026.01.003_bib200","doi-asserted-by":"crossref","first-page":"G147","DOI":"10.1152\/ajpgi.00284.2018","article-title":"microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail\/Slug pathway","volume":"317","author":"Chen","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib201","doi-asserted-by":"crossref","first-page":"123","DOI":"10.18632\/oncotarget.26498","article-title":"RASSF1C regulates miR-33a and EMT marker gene expression in lung cancer cells","volume":"10","author":"Amaar","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2026.01.003_bib202","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.18632\/oncotarget.3885","article-title":"MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine","volume":"6","author":"Liang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2026.01.003_bib203","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.3892\/ijo.2015.3187","article-title":"MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt\/beta-catenin\/ZEB1 signaling","volume":"47","author":"Qu","year":"2015","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib204","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI57275","article-title":"Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis","volume":"121","author":"Rayner","year":"2011","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.semcancer.2026.01.003_bib205","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.003376","article-title":"MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-\/- mice","volume":"1","author":"Horie","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.semcancer.2026.01.003_bib206","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/ATVBAHA.113.301732","article-title":"Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-\/- mice--brief report","volume":"33","author":"Rotllan","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib207","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCRESAHA.115.304164","article-title":"miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice","volume":"115","author":"Distel","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.semcancer.2026.01.003_bib208","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1172\/JCI81676","article-title":"MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis","volume":"125","author":"Ouimet","year":"2015","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.semcancer.2026.01.003_bib209","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.celrep.2017.10.023","article-title":"Genetic Dissection of the Impact of miR-33a and miR-33b during the Progression of Atherosclerosis","volume":"21","author":"Price","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcancer.2026.01.003_bib210","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long Noncoding RNA and Cancer: A New Paradigm","volume":"77","author":"Bhan","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2026.01.003_bib211","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nm.3981","article-title":"The emerging role of lncRNAs in cancer","volume":"21","author":"Huarte","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2026.01.003_bib212","article-title":"INK4\/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis","volume":"4","author":"Liu","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2026.01.003_bib213","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2016.02.025","article-title":"Long noncoding RNAs and atherosclerosis","volume":"248","author":"Zhou","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semcancer.2026.01.003_bib214","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.598817","article-title":"Long Non-Coding RNAs: the regulatory mechanisms, research strategies, and future directions in cancers","volume":"10","author":"Gao","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25179244","article-title":"The Role of Selected lncRNAs in Lipid Metabolism and Cardiovascular Disease Risk","volume":"25","author":"Gluba-Sagr","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib216","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3390\/ijms14011278","article-title":"ANRIL: molecular mechanisms and implications in human health","volume":"14","author":"Congrains","year":"2013","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib217","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2174\/0113895575295976240415045602","article-title":"ANRIL: A Long Noncoding RNA in Age-related Diseases","volume":"24","author":"Wang","year":"2024","journal-title":"Mini Rev. Med Chem."},{"key":"10.1016\/j.semcancer.2026.01.003_bib218","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1139\/bcb-2018-0126","article-title":"LncRNA-ANRIL inhibits cell senescence of vascular smooth muscle cells by regulating miR-181a\/Sirt1","volume":"97","author":"Tan","year":"2019","journal-title":"Biochem Cell Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib219","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.2217\/fon-2020-0470","article-title":"Long noncoding RNA ANRIL as a novel biomarker in human cancer","volume":"16","author":"Lou","year":"2020","journal-title":"Future Oncol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib220","first-page":"29","article-title":"Long Non-coding RNA ANRIL and Polycomb in Human Cancers and Cardiovascular Disease","volume":"394","author":"Aguilo","year":"2016","journal-title":"Curr. Top. Microbiol Immunol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib221","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fendo.2018.00405","article-title":"ANRIL: A lncRNA at the CDKN2A\/B Locus With Roles in Cancer and Metabolic Disease","volume":"9","author":"Kong","year":"2018","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib222","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/ATVBAHA.109.196832","article-title":"ANRIL expression is associated with atherosclerosis risk at chromosome 9p21","volume":"30","author":"Holdt","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib223","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ng.412","article-title":"New common variants affecting susceptibility to basal cell carcinoma","volume":"41","author":"Stacey","year":"2009","journal-title":"Nat. Genet"},{"key":"10.1016\/j.semcancer.2026.01.003_bib224","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ng.407","article-title":"Genome-wide association study identifies five susceptibility loci for glioma","volume":"41","author":"Shete","year":"2009","journal-title":"Nat. Genet"},{"key":"10.1016\/j.semcancer.2026.01.003_bib225","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ng.601","article-title":"A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci","volume":"42","author":"Bei","year":"2010","journal-title":"Nat. Genet"},{"key":"10.1016\/j.semcancer.2026.01.003_bib226","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ng.586","article-title":"Genome-wide association study identifies five new breast cancer susceptibility loci","volume":"42","author":"Turnbull","year":"2010","journal-title":"Nat. Genet"},{"key":"10.1016\/j.semcancer.2026.01.003_bib227","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/ATVBAHA.109.189522","article-title":"Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus","volume":"29","author":"Jarinova","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib228","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.18632\/aging.101863","article-title":"Long non-coding RNA CDKN2B-AS1 reduces inflammatory response and promotes cholesterol efflux in atherosclerosis by inhibiting ADAM10 expression","volume":"11","author":"Li","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.semcancer.2026.01.003_bib229","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1093\/hmg\/ddt299","article-title":"The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10","volume":"22","author":"Bochenek","year":"2013","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.semcancer.2026.01.003_bib230","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1111\/jcmm.13790","article-title":"The interplay of LncRNA ANRIL and miR-181b on the inflammation-relevant coronary artery disease through mediating NF-kappaB signalling pathway","volume":"22","author":"Guo","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.semcancer.2026.01.003_bib231","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/15476286.2015.1122164","article-title":"Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-kappaB pathway","volume":"13","author":"Zhou","year":"2016","journal-title":"RNA Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib232","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216127","article-title":"Analysis of ANRIL Isoforms and Key Genes in Patients with Severe Coronary Artery Disease","volume":"24","author":"Rodriguez-Esparragon","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib233","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s10038-006-0070-9","article-title":"Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction","volume":"51","author":"Ishii","year":"2006","journal-title":"J. Hum. Genet"},{"key":"10.1016\/j.semcancer.2026.01.003_bib234","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110359","article-title":"The role of long non-coding RNA MIAT in cancers","volume":"129","author":"Da","year":"2020","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.semcancer.2026.01.003_bib235","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/10717544.2019.1628116","article-title":"Up-regulation of MIAT aggravates the atherosclerotic damage in atherosclerosis mice through the activation of PI3K\/Akt signaling pathway","volume":"26","author":"Sun","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.semcancer.2026.01.003_bib236","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jb\/mvaa037","article-title":"Long non-coding RNA MIAT promotes cervical cancer proliferation and migration","volume":"168","author":"Zhang","year":"2020","journal-title":"J. Biochem"},{"key":"10.1016\/j.semcancer.2026.01.003_bib237","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/1440-1681.13538","article-title":"LncRNA Miat knockdown alleviates endothelial cell injury through regulation of miR-214-3p\/Caspase-1 signalling during atherogenesis","volume":"48","author":"Li","year":"2021","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib238","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/FJC.0000000000001061","article-title":"Long Noncoding RNA MALAT1 Regulates the Progression of Atherosclerosis by miR-330-5p\/NF-kappaB Signal Pathway","volume":"78","author":"Shi","year":"2021","journal-title":"J. Cardiovasc Pharm."},{"key":"10.1016\/j.semcancer.2026.01.003_bib239","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2023.12977","article-title":"Knockdown of the long non\u2011coding RNA MALAT1 ameliorates TNF\u2011alpha\u2011mediated endothelial cell pyroptosis via the miR\u201130c\u20115p\/Cx43 axis","volume":"27","author":"Yang","year":"2023","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.semcancer.2026.01.003_bib240","article-title":"Long non\u2011coding RNA MALAT1 regulates cholesterol accumulation in ox\u2011LDL\u2011induced macrophages via the microRNA\u201117\u20115p\/ABCA1 axis","author":"Liu","year":"2020","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.semcancer.2026.01.003_bib241","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.11830","article-title":"Long non\u2011coding RNA MEG3 inhibits cell migration and invasion of non\u2011small cell lung cancer cells by regulating the miR\u201121\u20115p\/PTEN axis","volume":"23","author":"Lv","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.semcancer.2026.01.003_bib242","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3729069","article-title":"lncRNA MEG3 Inhibits the Proliferation and Growth of Glioma Cells by Downregulating Bcl-xL in the PI3K\/Akt\/NF-kappaB Signal Pathway","volume":"2022","author":"Jia","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.semcancer.2026.01.003_bib243","first-page":"632","article-title":"MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma","volume":"118","author":"Zhang","year":"2017","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.semcancer.2026.01.003_bib244","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.jacc.2016.09.949","article-title":"Long Noncoding RNA Meg3 Controls Endothelial Cell Aging and Function: Implications for Regenerative Angiogenesis","volume":"68","author":"Boon","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib245","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101863","article-title":"Long non-coding RNA Meg3 deficiency impairs glucose homeostasis and insulin signaling by inducing cellular senescence of hepatic endothelium in obesity","volume":"40","author":"Cheng","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib246","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1536\/ihj.18-195","article-title":"Modulation of the Proliferation\/Apoptosis Balance of Vascular Smooth Muscle Cells in Atherosclerosis by lncRNA-MEG3 via Regulation of miR-26a\/Smad1 Axis","volume":"60","author":"Bai","year":"2019","journal-title":"Int Heart J."},{"key":"10.1016\/j.semcancer.2026.01.003_bib247","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.117506","article-title":"Multifaceted roles of Meg3 in cellular senescence and atherosclerosis","volume":"392","author":"Cheng","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semcancer.2026.01.003_bib248","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12935-019-1087-4","article-title":"LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21\/E-cadherin axis","volume":"20","author":"Wu","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.semcancer.2026.01.003_bib249","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/jcmm.15759","article-title":"Long non-coding RNA MEG3 promotes autophagy and apoptosis of nasopharyngeal carcinoma cells via PTEN up-regulation by binding to microRNA-21","volume":"25","author":"Lin","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.semcancer.2026.01.003_bib250","doi-asserted-by":"crossref","first-page":"9503","DOI":"10.1002\/jcp.26849","article-title":"Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7\/RASL11B signaling","volume":"233","author":"He","year":"2018","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib251","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/bph.16416","article-title":"Non-coding RNAs and their potential exploitation in cancer therapy-related cardiotoxicity","volume":"182","author":"Bernasconi","year":"2025","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.semcancer.2026.01.003_bib252","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.01.003_bib253","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.01.003_bib254","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.01.003_bib255","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1093\/eurheartj\/ehad596","article-title":"Long-term efficacy and safety of lerodalcibep in heterozygous familial hypercholesterolaemia: the LIBerate-HeFH trial","volume":"44","author":"Raal","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.semcancer.2026.01.003_bib256","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.01.003_bib257","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cell.2024.11.009","article-title":"A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor","volume":"188","author":"Mei","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.01.003_bib258","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-025-09017-8","article-title":"PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer","author":"Rademaker","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.01.003_bib259","doi-asserted-by":"crossref","first-page":"162","DOI":"10.37765\/ajmc.2021.88618","article-title":"Two steps forward, one step back: 50 years of societal value from LDL-C-lowering therapies","volume":"27","author":"MacEwan","year":"2021","journal-title":"Am. J. Manag Care"},{"key":"10.1016\/j.semcancer.2026.01.003_bib260","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12944-023-01955-4","article-title":"The association of statin therapy and cancer: a meta-analysis","volume":"22","author":"Chen","year":"2023","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.semcancer.2026.01.003_bib261","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.semcancer.2026.01.003_bib262","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.semcancer.2026.01.003_bib263","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2026.01.003_bib264","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002474","article-title":"Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer","volume":"9","author":"Nam","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib265","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10549-013-2473-6","article-title":"Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial","volume":"138","author":"Bjarnadottir","year":"2013","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.semcancer.2026.01.003_bib266","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/bjc.2014.283","article-title":"Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90alpha in human colorectal cancer","volume":"111","author":"Lee","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib267","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.biopha.2018.10.169","article-title":"MDR reversal and pro-apoptotic effects of statins and statins combined with flavonoids in colon cancer cells","volume":"109","author":"Palko-Labuz","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.semcancer.2026.01.003_bib268","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1256747","article-title":"Impact of statin use on breast cancer recurrence and mortality before and after diagnosis: a systematic review and meta-analysis","volume":"13","author":"Jia","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib269","first-page":"237","article-title":"Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies","volume":"25","author":"Liu","year":"2014","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.semcancer.2026.01.003_bib270","article-title":"Meta-analysis of studies using statins as a reducer for primary liver cancer risk","volume":"6","author":"Zhong","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2026.01.003_bib271","first-page":"1001","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"Cholest. Recurr. Events Trial Invest. N. Engl. J. Med"},{"key":"10.1016\/j.semcancer.2026.01.003_bib272","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2026.01.003_bib273","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.295.1.74","article-title":"Statins and cancer risk: a meta-analysis","volume":"295","author":"Dale","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.semcancer.2026.01.003_bib274","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1158\/1078-0432.CCR-20-1967","article-title":"Statins as Anticancer Agents in the Era of Precision Medicine","volume":"26","author":"Longo","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2026.01.003_bib275","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.622908","article-title":"Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity?","volume":"9","author":"Vona","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib276","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/s41598-020-57707-2","article-title":"Delineation of cell death mechanisms induced by synergistic effects of statins and erlotinib in non-small cell lung cancer cell (NSCLC) lines","volume":"10","author":"Otahal","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2026.01.003_bib277","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171137","article-title":"Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study","volume":"12","author":"Hung","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2026.01.003_bib278","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1111\/cas.14493","article-title":"Statins use and its impact in EGFR-TKIs resistance to prolong the survival of lung cancer patients: A Cancer registry cohort study in Taiwan","volume":"111","author":"Nguyen","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib279","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1158\/0008-5472.CAN-24-0970","article-title":"Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer","volume":"84","author":"Hillis","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2026.01.003_bib280","doi-asserted-by":"crossref","first-page":"e811","DOI":"10.1161\/CIR.0000000000001056","article-title":"Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association","volume":"145","author":"Beavers","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.semcancer.2026.01.003_bib281","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.trecan.2024.10.002","article-title":"A new enhancer for anti-PD-1\/PD-L1 immunotherapy: PCSK9 inhibition","volume":"11","author":"Sun","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib282","article-title":"Inhibition of PCSK9 enhances the antitumor effect of PD-1 inhibitor in colorectal cancer by promoting the infiltration of CD8(+) T cells and the exclusion of Treg cells","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib283","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/1078-0432.CCR-22-2807","article-title":"Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma","volume":"29","author":"Kelly","year":"2023","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.semcancer.2026.01.003_bib284","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004616","article-title":"Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating beta-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody","volume":"10","author":"Katoh","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib285","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1158\/0008-5472.CAN-24-2745","article-title":"SCD1 Inhibition Blocks the AKT-NRF2-SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma","volume":"85","author":"Sen","year":"2025","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.01.003_bib286","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/ERC-16-0533","article-title":"Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer","volume":"24","author":"Kimbung","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib287","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s11307-010-0457-z","article-title":"Measuring tumor aggressiveness and targeting metastatic lesions with fluorescent pHLIP","volume":"13","author":"Reshetnyak","year":"2011","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib288","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1089\/hum.2024.113","article-title":"Advances in MicroRNA Therapeutics: From Preclinical to Clinical Studies","volume":"35","author":"Brillante","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.semcancer.2026.01.003_bib289","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature13905","article-title":"MicroRNA silencing for cancer therapy targeted to the tumour microenvironment","volume":"518","author":"Cheng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.01.003_bib290","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/CIRCRESAHA.121.320296","article-title":"Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression","volume":"131","author":"Zhang","year":"2022","journal-title":"Circ. Res"},{"key":"10.1016\/j.semcancer.2026.01.003_bib291","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131102","article-title":"Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis","volume":"4","author":"Price","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.semcancer.2026.01.003_bib292","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1172\/JCI127125","article-title":"Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response","volume":"129","author":"Sahraei","year":"2019","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.semcancer.2026.01.003_bib293","article-title":"Tumor-Derived Exosomal miRNAs as Diagnostic Biomarkers in Non-Small Cell Lung Cancer","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib294","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021295","article-title":"Exosomal microRNA-92b Is a Diagnostic Biomarker in Breast Cancer and Targets Survival-Related MTSS1L to Promote Tumorigenesis","volume":"25","author":"Kan","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib295","doi-asserted-by":"crossref","first-page":"21796","DOI":"10.1002\/jcp.28942","article-title":"Circulating exosomal miRNAs in cardiovascular disease pathogenesis: New emerging hopes","volume":"234","author":"Aghabozorgi","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib296","unstructured":"NIH. Clinical trials using lncRNAs, <\u3008https:\/\/clinicaltrials.gov\/search?term=Long%20Noncoding%20RNA\u3009> (2025)."},{"key":"10.1016\/j.semcancer.2026.01.003_bib297","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18093","article-title":"Severity of coronary artery disease is associated with diminished circANRIL expression: A possible blood based transcriptional biomarker in East Africa","volume":"28","author":"Akan","year":"2024","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.semcancer.2026.01.003_bib298","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.omtn.2023.08.019","article-title":"Expression of NORAD correlates with breast cancer aggressiveness and protects breast cancer cells from chemotherapy","volume":"33","author":"Alves-Vale","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.semcancer.2026.01.003_bib299","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molcel.2013.08.027","article-title":"The imprinted H19 lncRNA antagonizes let-7 microRNAs","volume":"52","author":"Kallen","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.semcancer.2026.01.003_bib300","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/eurheartj\/ehx661","article-title":"No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: a meta-analysis of individual patient data","volume":"39","author":"Harvey","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.semcancer.2026.01.003_bib301","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.894685","article-title":"Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS","volume":"13","author":"Feng","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.semcancer.2026.01.003_bib302","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002196","article-title":"Genetic Assessment of Potential Long-Term On-Target Side Effects of PCSK9 (Proprotein Convertase Subtilisin\/Kexin Type 9) Inhibitors","volume":"12","author":"Nelson","year":"2019","journal-title":"Circ. Genom. Precis Med."},{"key":"10.1016\/j.semcancer.2026.01.003_bib303","first-page":"711","article-title":"Considerations for safe use of statins: liver enzyme abnormalities and muscle toxicity","volume":"83","author":"Gillett","year":"2011","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.semcancer.2026.01.003_bib304","article-title":"Statin Use in Patients With Cancer","volume":"4","author":"Chou","year":"2025","journal-title":"Drug Interact. Statin Usage JACC Adv."},{"key":"10.1016\/j.semcancer.2026.01.003_bib305","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.clpt.2006.09.003","article-title":"Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance","volume":"80","author":"Neuvonen","year":"2006","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.semcancer.2026.01.003_bib306","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1038\/onc.2012.6","article-title":"Targeting tumor cell metabolism with statins","volume":"31","author":"Clendening","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2026.01.003_bib307","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/1078-0432.CCR-10-2525","article-title":"A randomized phase II study of gefitinib plus simvastatin versus gefitinib alone in previously treated patients with advanced non-small cell lung cancer","volume":"17","author":"Han","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2026.01.003_bib308","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3816\/CLC.2008.n.036","article-title":"Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin","volume":"9","author":"Veeraputhiran","year":"2008","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib309","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100797","article-title":"First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors","volume":"34","author":"Falchook","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.semcancer.2026.01.003_bib310","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib311","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"van Zandwijk","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib312","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/09687688.2010.509285","article-title":"pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents","volume":"27","author":"Andreev","year":"2010","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib313","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310777","article-title":"Effects of miR-33 Deficiency on Metabolic and Cardiovascular Diseases: Implications for Therapeutic Intervention","volume":"24","author":"Ortega","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib314","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073630","article-title":"Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review","volume":"25","author":"Nappi","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib315","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ni.3754","article-title":"Nutrition, inflammation and cancer","volume":"18","author":"Zitvogel","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib316","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1158\/2159-8290.CD-22-0504","article-title":"Science-Driven Nutritional Interventions for the Prevention and Treatment of Cancer","volume":"12","author":"Mont\u00e9gut","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcancer.2026.01.003_bib317","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12967-018-1448-0","article-title":"The influence of diet on anti-cancer immune responsiveness","volume":"16","author":"Soldati","year":"2018","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.semcancer.2026.01.003_bib318","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.soc.2017.11.002","article-title":"Colon Cancer: What We Eat","volume":"27","author":"Pan","year":"2018","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"10.1016\/j.semcancer.2026.01.003_bib319","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/ijc.31198","article-title":"Food groups and risk of colorectal cancer","volume":"142","author":"Schwingshackl","year":"2018","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2026.01.003_bib320","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cmet.2015.12.015","article-title":"Obesity and Cancer: The Oil that Feeds the Flame","volume":"23","author":"Font-Burgada","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2026.01.003_bib321","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature17173","article-title":"High-fat diet enhances stemness and tumorigenicity of intestinal progenitors","volume":"531","author":"Beyaz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.01.003_bib322","doi-asserted-by":"crossref","DOI":"10.1084\/jem.2021004202072022c","article-title":"Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function","volume":"219","author":"Dyck","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2026.01.003_bib323","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","article-title":"Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity","volume":"183","author":"Ringel","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.01.003_bib324","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.aat8515","article-title":"High-fructose corn syrup enhances intestinal tumor growth in mice","volume":"363","author":"Goncalves","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2026.01.003_bib325","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer\u2013immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.01.003_bib326","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/2326-6066.CIR-20-0396","article-title":"Fructose Promotes Cytoprotection in Melanoma Tumors and Resistance to Immunotherapy","volume":"9","author":"Kuehm","year":"2021","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.semcancer.2026.01.003_bib327","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108863","article-title":"Autophagy in major human diseases","volume":"40","author":"Klionsky","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.semcancer.2026.01.003_bib328","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.cell.2016.07.031","article-title":"Metabolic Control of Longevity","volume":"166","author":"Lopez-Otin","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.01.003_bib329","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/oxfordjournals.aje.a114480","article-title":"The diet and 15-year death rate in the seven countries study","volume":"124","author":"Keys","year":"1986","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.semcancer.2026.01.003_bib330","article-title":"Mediterranean diet and cancer: epidemiological evidence and mechanism of selected aspects","volume":"13","author":"Grosso","year":"2013","journal-title":"BMC Surg."},{"key":"10.1016\/j.semcancer.2026.01.003_bib331","doi-asserted-by":"crossref","first-page":"a1344","DOI":"10.1136\/bmj.a1344","article-title":"Adherence to Mediterranean diet and health status: meta-analysis","volume":"337","author":"Sofi","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.semcancer.2026.01.003_bib332","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.semcancer.2026.01.003_bib333","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/jamainternmed.2015.4838","article-title":"Mediterranean Diet and Invasive Breast Cancer Risk Among Women at High Cardiovascular Risk in the PREDIMED Trial: A Randomized Clinical Trial","volume":"175","author":"Toledo","year":"2015","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.semcancer.2026.01.003_bib334","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12967-024-05176-w","article-title":"Adherence to the Mediterranean Diet and its association with gastric cancer: health benefits from a Planeterranean perspective","volume":"22","author":"Reytor-Gonzalez","year":"2024","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.semcancer.2026.01.003_bib335","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1136\/heartjnl-2022-321930","article-title":"Primary prevention of cardiovascular disease in women with a Mediterranean diet: systematic review and meta-analysis","volume":"109","author":"Pant","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.semcancer.2026.01.003_bib336","doi-asserted-by":"crossref","first-page":"13023","DOI":"10.1021\/acs.jafc.3c08851","article-title":"Antiangiogenic Potential of an Olive Oil Extract: Insights from a Proteomic Study","volume":"72","author":"Marrero","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.semcancer.2026.01.003_bib337","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3945\/jn.112.164616","article-title":"Adherence to the Mediterranean diet pattern has declined in Spanish adults","volume":"142","author":"Leon-Munoz","year":"2012","journal-title":"J. Nutr."},{"key":"10.1016\/j.semcancer.2026.01.003_bib338","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.mayocp.2019.03.035","article-title":"Consumption of Ultra-Processed Foods and Mortality: A National Prospective Cohort in Spain","volume":"94","author":"Blanco-Rojo","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.semcancer.2026.01.003_bib339","doi-asserted-by":"crossref","DOI":"10.3390\/nu14153223","article-title":"Geographical and Temporal Variability of Ultra-Processed Food Consumption in the Spanish Population: Findings from the DRECE Study","volume":"14","author":"Romero Ferreiro","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.semcancer.2026.01.003_bib340","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41423-022-00844-7","article-title":"Correction: Resident and migratory adipose immune cells control systemic metabolism and thermogenesis","volume":"19","author":"Man","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib341","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: endogenous regulators of infection and inflammation","volume":"16","author":"Basil","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib342","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.smim.2015.03.013","article-title":"Atherosclerosis - A matter of unresolved inflammation","volume":"27","author":"Viola","year":"2015","journal-title":"Semin Immunol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib343","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/pros.23218","article-title":"Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression","volume":"76","author":"Liang","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.semcancer.2026.01.003_bib344","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115528","article-title":"Omega-3 Lipid Mediators: Modulation of the M1\/M2 Macrophage Phenotype and Its Protective Role in Chronic Liver Diseases","volume":"24","author":"Videla","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib345","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1089\/ars.2012.4581","article-title":"Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases","volume":"18","author":"Del Rio","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.semcancer.2026.01.003_bib346","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007653","article-title":"Antioxidants accelerate lung cancer progression in mice","volume":"6","author":"Sayin","year":"2014","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.semcancer.2026.01.003_bib347","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13578-021-00731-0","article-title":"Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1","volume":"11","author":"Zhang","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.semcancer.2026.01.003_bib348","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/advances\/nmaa072","article-title":"Intake of omega-6 Polyunsaturated Fatty Acid-Rich Vegetable Oils and Risk of Lifestyle Diseases","volume":"11","author":"Yamashima","year":"2020","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.semcancer.2026.01.003_bib349","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3711371","article-title":"Dietary fatty acid regulation of the NLRP3 inflammasome via the TLR4\/NF-kappaB signaling pathway affects chondrocyte pyroptosis","volume":"2022","author":"Jin","year":"2022","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.semcancer.2026.01.003_bib350","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101869","article-title":"Dietary patterns and biomarkers of oxidative stress and inflammation: a systematic review of observational and intervention studies","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib351","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.cmet.2016.05.027","article-title":"Effects of sex, strain, and energy intake on hallmarks of aging in mice","volume":"23","author":"Mitchell","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2026.01.003_bib352","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000446346","article-title":"Beyond Calories: an Integrated approach to promote health, longevity, and well-being","volume":"63","author":"Bertozzi","year":"2017","journal-title":"Gerontology"},{"key":"10.1016\/j.semcancer.2026.01.003_bib353","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nsmb.1824","article-title":"Role for the MOV10 RNA helicase in polycomb-mediated repression of the INK4a tumor suppressor","volume":"17","author":"El Messaoudi-Aubert","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.semcancer.2026.01.003_bib354","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature08801","article-title":"Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice","volume":"464","author":"Visel","year":"2010","journal-title":"Nature"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X26000106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X26000106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:26:33Z","timestamp":1777605993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X26000106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":354,"alternative-id":["S1044579X26000106"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2026.01.003","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2026.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 IR Sant Pau. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}